Erschienen in:
14.02.2021 | Brief Report
Changes in antimicrobial resistance and outcomes of health care–associated infections
verfasst von:
Mehtap Aydın, Emel Azak, Hüseyin Bilgin, Sirin Menekse, Ali Asan, Habibe Tülin Elmaslar Mert, Zerrin Yulugkural, Lutfiye Nilsun Altunal, Çiğdem Ataman Hatipoğlu, Gunay Tuncer Ertem, Elif Sargın Altunok, Melike Hamiyet Demirkaya, Sevil Alkan Çeviker, Fethiye Akgul, Zeynep Memis, Petek Konya, Alpay Azap, Gule Aydin, Derya Korkmaz, Zehra Çagla Karakoç, Derya Yapar, Faruk Karakecili, Ozgur Gunal, Siran Keske, Mahir Kapmaz, Cigdem Kader, Aslıhan Demirel, Önder Ergönül
Erschienen in:
European Journal of Clinical Microbiology & Infectious Diseases
|
Ausgabe 8/2021
Einloggen, um Zugang zu erhalten
Abstract
To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.